top of page


Olaris offers clinical diagnostics through our CLIA lab  & metabolomics services

myOLARIS-KTdx is a urine based metabolomics and ML-based signature to detect graft injury in kidney transplant patients. The assay has excellent ability to detect and differentiate biopsy confirmed graft injury including subclinical rejection, rejection and PVAN (polyomavirus-associated nephropathy). With a broad clinical use case, and both high positive predictive value (PPV) and negative predictive value (NPV), myOLARIS-KTdx is poised to transform care.  We will be launching our LDT later this year and are actively recruiting patients/physicians to participate in expanded trials.  Contact us below to learn more. 

myOLARIS-KTdx Information Request
Are you a transplant patient?
Are you a healthcare provider?

Thank you for your interest in myOLARIS-KTdx

bottom of page